InnoPran XL and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of InnoPran XL and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: propranolol
Brand name: Hemangeol, Inderal LA, Inderal XL, InnoPran XL, Inderal, InnoPran XL
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- InnoPran XL-Moxifloxacin
- InnoPran XL-Moxifloxacin (Systemic)
- InnoPran XL-Moxifloxacin Hydrochloride
- InnoPran XL-Moxifloxacin Injection
- InnoPran XL-Moxifloxacin Intravenous
- InnoPran XL-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Inomax
- Moxetumomab pasudotox-tdfk Intravenous-INOmax inhalation gas
- Moxetumomab pasudotox-tdfk Intravenous-Inotersen
- Moxetumomab pasudotox-tdfk Intravenous-Inotersen Sodium
- Moxetumomab pasudotox-tdfk Intravenous-Inotersen Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Inotuzumab ozogamicin